GBP1 restricts infection in IFNγ-treated human mesenchymal stromal cells (MSCs) and lung epithelial cells (i.e., A549 cells) but not myeloid-derived cells (i.e., HAP1 cells) (Qin et al., 2017; Ohshima et al., 2014; Johnston et al., 2016). The gene discussed is IFNG; the disease is infection.